Social stigmatization of skin conditions: La Roche-Posay reveals mental toll of eczema and scars, via Personal Care Insights

By Sabine Waldeck

La Roche-Posay has found that scarring and eczema take a “profound” psychological toll on people. Respondents to the Scars of Life Epidemiological Study reported diminished self-esteem, social stigmatization, and limited personal and social life choices. 

The dermocosmetic brand surveyed 30,000 adults across 27 countries to investigate how scars and skin conditions are “not just a dermatological issue,” but also a mental health one. Half the world’s population bears at least one scar — a mark left by injury, skin disease, cancer treatment side effects, or sun exposure. 

La Roche-Posay reveals that scars significantly impact daily life, sometimes even for a lifetime. Seventy-one percent of acne patients express lower self-confidence, and 47% of eczema sufferers in childhood and adulthood prefer to hide themselves.

Half of the participants reported being bullied, 36% felt excluded, and 43% struggled with negative self-image. Eczema was shown to impact 40% of respondents’ love lives or sexuality.

Earlier this year, the WHO recognized skin health as a global health priority, urging action on physical conditions and the stigma, anxiety, and distress they cause. The Scars of Life Epidemiological Study found that 50% of cancer patients interrupt treatment due to skin-related side effects.

Alongside the study, La Roche-Posay launched its first long-form documentary: Scars of Life. The video explores the emotional and physical impact of scars, from acne to cancer, and other skin conditions.